APOBEC3G Genetic Variants and Their Influence on the Progression to AIDS†

AUTOR(ES)

An, Ping

FONTE

American Society for Microbiology

RESUMO

The cytosine deaminase APOBEC3G, in the absence of the human immunodeficiency virus type 1 (HIV-1) accessory gene HIV-1 viral infectivity factor (vif), inhibits viral replication by introducing G→A hypermutation in the newly synthesized HIV-1 DNA negative strand. We tested the hypothesis that genetic variants of APOBEC3G may modify HIV-1 transmission and disease progression. Single nucleotide polymorphisms were identified in the promoter region (three), introns (two), and exons (two). Genotypes were determined for 3,073 study participants enrolled in six HIV-AIDS prospective cohorts. One codon-changing variant, H186R in exon 4, was polymorphic in African Americans (AA) (f = 37%) and rare in European Americans (f < 3%) or Europeans (f = 5%). For AA, the variant allele 186R was strongly associated with decline in CD4 T cells (CD4 slope on square root scale: −1.86, P = 0.009), The 186R allele was also associated with accelerated progression to AIDS-defining conditions in AA. The in vitro antiviral activity of the 186R enzyme was not inferior to that of the common H186 variant. These studies suggest that there may be a modifying role of variants of APOBEC3G on HIV-1 disease progression that warrants further investigation.

Documentos Relacionados

• APOBEC3G Targets Specific Virus Species
• Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G
• Influência dos polimofismos de nucleotídeo único (SNPs) da APOBEC3G na dinâmica populacional da infecção pelo HIV-1
• APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
• Ancient Adaptive Evolution of the Primate Antiviral DNA-Editing Enzyme APOBEC3G